Vaccination history and risk of childhood leukaemia

International Journal of Epidemiology

Volumn 34, Issue 5, 2005, Pages 1100-1109

  Ma, Xiaomei ^a   Does, Monique B ^b   Metayer, Catherine ^b   Russo, Carolyn ^c   Wong, Alan ^c   Buffler, Patricia A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Case control studies; Child; Leukaemia; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE;

HEALTH AND DISEASE;

ADOLESCENT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DIPHTHERIA; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HEPATITIS B; HUMAN; INFANT; INFLUENZA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; PERTUSSIS; POLIOMYELITIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; RUBELLA; TETANUS; TREATMENT PLANNING; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIPHTHERIA TOXOID; EDUCATIONAL STATUS; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; INCOME; INFANT; LEUKEMIA; MALE; MEASLES-MUMPS-RUBELLA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS; RISK FACTORS; TETANUS TOXOID; VACCINES;

HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 27544500770     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyi113     Document Type: Article

References (24)

1. Innis MD. Immunisation and childhood leukaemia. Lancet 1965;1:605.
2. Buckley J, Buckley C, Ruccione K et al. Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. Leukemia 1994;8:856-64.
3. Kneale GW, Stewart AM, Wilson LM. Immunizations against infectious diseases and childhood cancers. Cancer Immunol Immunother 1986;21:129-32.
4. McKinney PA, Cartwright RA, Saiu JM et al. The inter-regional epidemiological study of childhood cancer (IRESCC): A case control study of aetiological factors in leukaemia and lymphoma Arch Dis Child 1987;62:279-87.
5. Hartley AL, Birch JM, McKinney PA et al. The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): Past medical history in children with cancer. J Epidemiol Community Health 1988; 42:235-42.
6. Nishi M, Miyake H. A case-control study of non-T cell acute lymphoblastic leukaemia of children in Hokkaido, Japan. J Epidmiol Community Health 1989;43:352-55.
7. Kaatsch P, Kaletsch U, Krummenauer F et al. Case control study on childhood leukemia in Lower Saxony, Germany. Klin Pädiatr Basic considerations, methodology, and summary of results. 1996;208:79-85.
8. Kaatsch P, Kaletsch U, Meinert R et al. German case control study on childhood leukaemia - basic considerations, methodology and summary of the results. Klin Padiatr 1998;210:185-91.
9. Groves FD, Gridley G, Wacholder S et al. Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA. Br J Cancer 1999;81:175-78.
10. Schüz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J. Association of childhood leukaemia with factors related to the immune system. Br J Cancer 1999;80:585-90.
11. Salonen T, Saxen L. Risk indicators in childhood malignancies. Int J Cancer 1975;15:941-46.
12. Petridou E, Trichopoulos D, Kalapothaki V et al. The risk profile of childhood leukaemia in Greece: A nationwide case-control study. Br J Cancer 1997:76:1241-47.
13. Dockerty JD, Skegg DC, Elwood JM, Herbison GP, Becroft DM, Lewis ME. Infections, vaccinations, and the risk of childhood leukaemia. Br J Cancer 1999;80:1483-89.
14. Ma X, Buffler PA, Layefsky M, Does MB, Reynolds P. Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol 2004:159:915-21.
15. Auvinen A, Hakulinen T, Groves F. Haemophilus influenzae type B vaccination and risk of childhood leukaemia in a vaccine trial in Finland. Br J Cancer 2000;83:956-58.
16. Groves F, Sinha D, Auvinen A. Haemophilus influenzae type b vaccine formulation and risk of childhood leukaemia. Br J Cancer 2002;87:511-12.
17. Martinetti M, Cuccia M, Daielli C et al. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity. Vaccine 1995;13:555-60.
18. Martinetti M, De Silvestri A, Belloni C et al. Humoral response to recombinant hepatitis B virus vaccine at birth: Role of HLA and beyond. Clin Immunol 2000;97:234-40.
19. Taylor G, Dearden S, Payne N et al. Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. Br J Cancer 1998;78:561-65.
20. Taylor GM, Dearden S, Ravetto P et al. Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPBI*0201. Hum Mol Genet 2002;11:1585-97.
21. Ma X, Does M, Buffler PA, Wiencke JK. Hepatitis B vaccination and the risk of childhood leukemia. Poster presented at the 93rd Annual Conference of the American Association for Cancer Research, 2002, San Francisco, CA, USA.
22. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACID). MMWR Recomm Rep 1991;40:1-25.
23. Cochran W. Planning and Analysis of Observational Studies. New York: John Wiley and Sons, 1983.
24. Little J. Epidemiology of Childhood Cancer. Lyon, France: International Agency for Research on Cancer, 1999.